Table 4.
Importance of the criteria on which GPs based their decision about the continuation or discontinuation of the NSAIDa
| Criteria for choosing | Meanb (95% CI) | GPs’ choice | |||
|---|---|---|---|---|---|
| n | Continuation of NSAID, mean (95% CI) | Discontinuation of NSAID, mean (95% CI) | P-valuec | ||
| Risk–benefit ratio of the prescription (n = 1173) | 7.9 (7.78 to 8.05) | 1162 | 7.3 (7.05 to 7.48) | 8.2 (8.04 to 8.37) | <0.001 |
| Patients’ understanding of the risks of the NSAID (n = 1175) | 7.1 (6.94 to 7.27) | 1162 | 7.3 (7.02 to 7.52) | 7.0 (6.81 to 7.23) | 0.14 |
| The patients’ preferences (n = 1174) | 3.2 (3.05 to 3.36) | 1163 | 4.2 (3.93 to 4.47) | 2.7 (2.56 to 2.92) | <0.001 |
| Presence of family/friends (n = 1170) | 3.4 (3.19 to 3.56) | 1160 | 4.0 (3.62 to 4.31) | 3.1 (2.89 to 3.32) | <0.001 |
a
Score assessed from 0–10 (weighted data).
b
Among all responding GPs.
c
Two-sample t-test. CI = confidence interval. NSAID = non-steroidal anti-inflammatory drug.